Cushing's Syndrome clinical trials at UCSF
1 research study open to eligible people
Cushing's syndrome is a condition caused by high levels of cortisol in the body. UCSF is studying how a medicine called osilodrostat works in young people with Cushing's syndrome. The trial tests how the medicine is absorbed, its effects on the body, and its tolerance.
Showing trials for
(PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
open to eligible people ages 2-17
Multicenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmacodynamics, and tolerability of osilodrostat in children and adolescent patients with Cushing's syndrome.
San Francisco, California and other locations
Last updated: